3McLaren BK, Smith J, Schuyler PA, et al. Adenomyoepithelioma clinical, histologic, and immunohistologic evaluation of a series of related lesions[J]. Am J Sury Pathol,2005, 29(10) : 1294 - 1299.
4Howlett DC, Mason CH, Biswas S, et al. Adenomyoepithelioma of the Breast: spectrum of disease with, associated imaging and pathology [ J ]. Am J Roentgenol, 2003,180 (3) : 799 - 803.
5Nadelman CM, Leslie KO, Fishbein MC. " Benign," metastasizing adenomyoepithelioma of the breast: a report of 2 cases[ J]. Arch Pathol Lab Med, 2006,130(9) : 1349 - 1353.
6Tavassoli FA, Devilee P. World Health Organigation classification of tumours. Pathological and genetic of tumours of the breast and female genital organs [ M ]. Lyon: IARC Press, 2003.86 - 88.
7Berna JD, Arcas I, Ballester A, et al. Adenomyoepithelioma of the breast in a male[J]. Am J Roentgenol, 1997,169(3) :917 - 918.
8Tavassoli FA. Myoepithelial lasions of the breast. Myoepitheliosis, adenomyoepithelioma and myoepithelial carcinoma [ J ]. Am J Surg Pathol, 1991,15(6) :554 - 568.
9Bult P, Verwiel JM, Wobbes T et al. Malignant denomyoepithelioma of the breast with metastasis in the thyroid gland 12 years after excision of the primary tumor. Case report and review of the literature [ J ]. Virchows Arch, 2000,436(2) : 158-166.
1Lerwill MF, Current practical applications of diagnostic immunohistochemistry in breast pathology [ J ]. Am J Surg Pathol,2004,28(8) : 1076 - 1091.
2Sloane JP, Trott PA, Lakhani SR. Biopsy pathology of the breast[M] .2rd ed.London: Arnold,2001.2-4.
3Rosen PP. Rosen' s breast pathology [ M ], 2rd ed. Philadelphia:Lippincott Williams & Wilkins.2001,1 - 19.
4Dabbs DJ. Diagnostic immunohistochemistry[ M ]. New York: Churchill Livingstone, 2002.536 - 578.
5Nayar R, Breland C, Bedrossian U, et al. Immunoreactivity of ductal cells with putative myoepithelial markers: a potential pitfall in.breast carcinoma [J] .Ann Diagn Pathol,1999,3(3) : 165 - 173.
6Werling RW, Hwang H, Yaziji H, et al.immunohistochemical of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain[J]. Am J Surg Pathol, 2003,27:82 - 90.
7Barbareschi M, Pecciarini L,Cangi MG, et al.p63,a p53 homologue,is a selective nuclear marker of myoepithelial cells of the human breast [J]. Am J Surg Pathol,2001,25(8) :1054- 1060.
8Moritani S, Kushima R, Sugihara H, et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections [J] .Mod Pathol,2002,15(4) :397- 405.
9Matsushima S,Mori M, Adachi Y, et al.S-100 protein positive human breast carcinomas: an immunohistochemical study [J] .J Surg Oncol,1994,55(2) :108 - 113.
10Ichihara S, Koshikawa T, Nakamura S, et al. Epithelial hyperplasis of usual type expresses both S-100α and S-100β in a heterogeneous pattern but ductal carcinoma in situ can express only S-100 α in a monotonous pattern[J]. Histopathology, 1997,30(6) :533 - 541.
